{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:41:53Z","timestamp":1760370113786,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 3214100","U1903290"],"award-info":[{"award-number":["NSFC 3214100","U1903290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["81971520","82171775"],"award-info":[{"award-number":["81971520","82171775"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z141107002514064"],"award-info":[{"award-number":["Z141107002514064"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z191100006619111","Z191100006619112"],"award-info":[{"award-number":["Z191100006619111","Z191100006619112"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key research and development program in Xinjiang Uygur Autonomous Region","award":["2022B03002-2"],"award-info":[{"award-number":["2022B03002-2"]}]},{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RDGS2022-05"],"award-info":[{"award-number":["RDGS2022-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10067-025-07493-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T05:36:34Z","timestamp":1747892194000},"page":"2647-2656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis"],"prefix":"10.1007","volume":"44","author":[{"given":"Peishi","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanzhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4822-0096","authenticated-orcid":false,"given":"Shixiong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"6","key":"7493_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS (2023) Rheumatoid arthritis - common origins divergent mechanisms. N Engl J Med 388(6):529\u2013542","journal-title":"N Engl J Med"},{"issue":"9","key":"7493_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/acr2.11468","volume":"4","author":"AJ Cordisco","year":"2022","unstructured":"Cordisco AJ, Olave M, George MD, Baker JF (2022) Identifying factors associated with treatment response in rheumatoid arthritis clinical trials. ACR Open Rheumatol 4(9):811\u2013818","journal-title":"ACR Open Rheumatol"},{"issue":"23","key":"7493_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219","journal-title":"N Engl J Med"},{"issue":"2","key":"7493_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heineg\u00e5rd D, Saxne T (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64(2):196\u2013201","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7493_CR5","first-page":"20","volume":"24","author":"MA van Leeuwen","year":"1997","unstructured":"van Leeuwen MA, van Rijswijk MH, Sluiter WJ, van Riel PL, Kuper IH, van de Putte LB et al (1997) Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 24(1):20\u20137","journal-title":"J Rheumatol"},{"key":"7493_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/rai2.12025","volume":"2","author":"XCY Zhao","year":"2022","unstructured":"Zhao XCY, Wen W, Cheng Y, Li R, Liu X et al (2022) Identification of lipopolysaccharide-binding protein as a novel citrullinated autoantigen in rheumatoid arthritis. Rheumatol Autoimmun 2:5\u201314","journal-title":"Rheumatol Autoimmun"},{"key":"7493_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","volume":"69","author":"BI Hudson","year":"2018","unstructured":"Hudson BI, Lippman ME (2018) Targeting RAGE signaling in inflammatory disease. Annu Rev Med 69:349\u2013364","journal-title":"Annu Rev Med"},{"issue":"1","key":"7493_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10456-008-9093-5","volume":"11","author":"JR van Beijnum","year":"2008","unstructured":"van Beijnum JR, Buurman WA, Griffioen AW (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11(1):91\u201399","journal-title":"Angiogenesis"},{"issue":"7","key":"7493_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/hc0702.104183","volume":"105","author":"G Basta","year":"2002","unstructured":"Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C et al (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105(7):816\u2013822","journal-title":"Circulation"},{"issue":"7","key":"7493_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97(7):889\u2013901","journal-title":"Cell"},{"issue":"6","key":"7493_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00296-004-0456-y","volume":"25","author":"S Drinda","year":"2005","unstructured":"Drinda S, Franke S, R\u00fcster M, Petrow P, Pullig O, Stein G, Hein G (2005) Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis. Rheumatol Int 25(6):411\u2013413","journal-title":"Rheumatol Int"},{"issue":"6","key":"7493_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1365-3083.2012.02691.x","volume":"75","author":"CY Ma","year":"2012","unstructured":"Ma CY, Ma JL, Jiao YL, Li JF, Wang LC, Yang QR et al (2012) The plasma level of soluble receptor for advanced glycation end products is decreased in patients with systemic lupus erythematosus. Scand J Immunol 75(6):614\u2013622","journal-title":"Scand J Immunol"},{"issue":"4","key":"7493_CR13","doi-asserted-by":"publisher","first-page":"R817","DOI":"10.1186\/ar1749","volume":"7","author":"R Pullerits","year":"2005","unstructured":"Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A (2005) Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7(4):R817\u2013R824","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"7493_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.semarthrit.2012.07.002","volume":"42","author":"LS Tam","year":"2013","unstructured":"Tam LS, Shang Q, Li EK, Wong S, Li RJ, Lee KL et al (2013) Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis\u2013a prospective study. Semin Arthritis Rheum 42(4):333\u2013345","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"7493_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/14397595.2018.1551107","volume":"29","author":"MR Jafari Nakhjavani","year":"2019","unstructured":"Jafari Nakhjavani MR, Jafarpour M, Ghorbanihaghjo A, Abedi Azar S, Malek MA (2019) Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients. Mod Rheumatol 29(6):943\u2013948","journal-title":"Mod Rheumatol"},{"issue":"10","key":"7493_CR16","first-page":"3450","volume":"26","author":"M Okuyucu","year":"2022","unstructured":"Okuyucu M, Kehribar DY, \u00c7elik ZB, \u00d6zgen M (2022) An investigation of the relationship between rheumatological diseases and soluble receptor for advanced glycation end products. Eur Rev Med Pharmacol Sci 26(10):3450\u20133455","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"7493_CR17","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7493_CR18","first-page":"233","volume":"36","author":"W Wen","year":"2018","unstructured":"Wen W, Li Y, Cheng Y, He J, Jia R, Li C et al (2018) Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis. Clin Exp Rheumatol 36(2):233\u2013240","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"7493_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1189\/jlb.0409230","volume":"86","author":"R Ramasamy","year":"2009","unstructured":"Ramasamy R, Yan SF, Schmidt AM (2009) RAGE: therapeutic target and biomarker of the inflammatory response\u2013the evidence mounts. J Leukoc Biol 86(3):505\u2013512","journal-title":"J Leukoc Biol"},{"issue":"3","key":"7493_CR20","first-page":"154","volume":"36","author":"P Younessi","year":"2011","unstructured":"Younessi P, Yoonessi A (2011) Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci 36(3):154\u2013166","journal-title":"Iran J Med Sci"},{"issue":"11","key":"7493_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146(11):797\u2013808","journal-title":"Ann Intern Med"},{"issue":"1","key":"7493_CR22","first-page":"47","volume":"27","author":"N Graudal","year":"2000","unstructured":"Graudal N, Tarp U, Jurik AG, Gall\u00f8e AM, Garred P, Milman N, Graudal HK (2000) Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression. J Rheumatol 27(1):47\u201357","journal-title":"J Rheumatol"},{"issue":"7","key":"7493_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","volume":"43","author":"MJ Plant","year":"2000","unstructured":"Plant MJ, Williams AL, O\u2019Sullivan MM, Lewis PA, Coles EC, Jessop JD (2000) Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 43(7):1473\u20131477","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07493-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:12:34Z","timestamp":1757171554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07493-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7493"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07493-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Ethics Committee of Peking University People\u2019s Hospital (approval no.2020PHB036-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}